Evidence map›Paper›PMID 29142409›Full record

ArticlePharmacognosy magazine2017

Reversible Testicular Toxicity of Piperine on Male Albino Rats.

Gopichand Chinta, Mohane Selvaraj Coumar, Latha Periyasamy

Abstract read
In one paragraph

Article in Pharmacognosy magazine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. The attenuation effect of low piperinePharmaceutical biology · 2022
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Testis Toxicants: Lesson from Traditional Chinese Medicine (TCM).Advances in experimental medicine and biology · 2021
    Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Gopichand ChintaDBT-Interdesciplinary Program in Life sciences, Pondicherry University, Puducherry, India.
Mohane Selvaraj CoumarCentre for Bioinformatics, Pondicherry University, Kalapet, Puducherry, India.
Latha PeriyasamyDepartment of Biochemistry and Molecular Biology, School of Life Sciences, Pondicherry Universty, Kalapet, Puducherry, India.
Pondicherry University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPiperine was widely used in traditional medicine for inducing sterility and abortion.

objectiveTo evaluate the effect of the piperine on testis of male albino rats. MATERIALS AND

methodsAdult male rats were divided into four groups (

resultsPiperine significantly decreased the reproductive organ weights in groups ED and E4D. Piperine induced hormonal imbalance by altering the serum levels of follicle-stimulating hormone, luteinizing hormone, sex hormone binding globulin, serum, and testicular testosterone in groups ED and E4D. Furthermore, piperine decreased the activity of germ cell markers and Leydig cellular steroidogenic enzymes in the groups ED and E4D after 60 days. All the above-altered values returned to normal levels after withdrawal period. Histopathological findings also supported the above findings.

conclusionFrom the above data, it can be concluded that piperine could be a good lead molecule for the development of reversible oral male contraceptive. SUMMARY: Piperine was employed for the contraceptive purposes in traditional medicinePiperine significantly impaired the spermatogenesis by decreasing the testicular hormone synthesis in groups ED and E4DPiperine disrupted the testicular antioxidant system by promoting the ROS production and hydroxyl radical generation in rat testis in groups ED and E4DHistopathological evidence supported the disruption of spermatogenesis by piperineAll the effects of piperine after the treatment period (i.e. 60 days) were back to normal after the withdrawal period (i.e., after 120 days).

Indexed as

Androgen binding proteingerm cell markersmale oral contraceptivesserum hormonessex hormone binding globulin

Identifiers

PMID29142409
PMCPMC5669092
OpenAlexW2737079173

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.